Brain Dev 30:3142 Januszewicz E, Bekisz M, Mozrzymas JW, Nalecz KA (2010) High affinity carnitine transporters from OCTN family in neural cells
They don't want to look "done"
Product Information and Documentation We seek to describe products accurately, but images, packaging, specifications, availability, pricing, and documentation may be corrected or updated
The medication also slows digestion and reduces appetite
Assuming the remaining Phase 3 data continues to support both safety and efficacy, and the FDA review process moves forward without delays, industry projections currently point to a possible late 2026 to 2027 timeline